T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Aude G. Chapuis(University of Washington), Daniel Egan(University of Washington), Merav Bar(University of Washington), Thomas M. Schmitt(Fred Hutch Cancer Center), Megan S. McAfee(Fred Hutch Cancer Center), Kelly G. Paulson(University of Washington), Valentin Voillet(Fred Hutch Cancer Center), Raphaël Gottardo(Fred Hutch Cancer Center), Gunnar B. Ragnarsson(Reykjavík University), Marie Bleakley(University of Washington), Cecilia C.S. Yeung(University of Washington), Petri R. Muhlhauser(University of Washington), Hieu Nguyen(Alpine Immune Sciences (United States)), Lara Kropp(Fred Hutch Cancer Center), Luca Castelli(Fred Hutch Cancer Center), Felecia Wagener(Fred Hutch Cancer Center), Daniel Hunter(Fred Hutch Cancer Center), Marcus Lindberg(Fred Hutch Cancer Center), Kristen W. Cohen(Fred Hutch Cancer Center), Aaron Seese(Fred Hutch Cancer Center), M. Juliana McElrath(University of Washington), Natalie Duerkopp(Fred Hutch Cancer Center), Ted Gooley(Fred Hutch Cancer Center), Philip D. Greenberg(University of Washington)
Nature Medicine
June 24, 2019
10.1038/s41591-019-0472-9
Cited by 316Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis